Skip to main content
SpringerLink
Log in

Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer

  • Review
  • Published:
Journal of Cell Communication and Signaling Aims and scope

Abstract

Epigenetics refers to heritable changes in gene expression that are independent of alterations in DNA sequence. It is now accepted that disruption of epigenetic mechanisms plays a key role in the pathogenesis of cancer: culminating in altered gene function and malignant cellular transformation. DNA methylation and histone modifications are the most widely studied changes but non-coding RNAs such as miRNAs are also considered part of the epigenetic machinery. The insulin-like growth factor (IGF) axis is composed of two ligands, IGF-I and –II, their receptors and six high affinity IGF binding proteins (IGFBPs). The IGF axis plays a key role in cancer development and progression. As IGFBP genes have consistently been identified among the most common to be aberrantly altered in tumours, this review will focus on epigenetic regulation of IGFBP-3 in cancer for which the majority of evidence has been obtained.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Amato RJ (2007) Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy. Clin Genitourin Cancer 5:422–6

    Article  CAS  PubMed  Google Scholar 

  • Baxter RC (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14:329–41

    Article  CAS  PubMed  Google Scholar 

  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR et al (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646–9

    Article  CAS  PubMed  Google Scholar 

  • Butt AJ, Martin JL, Dickson KA, McDougall F, Firth SM, Baxter RC (2004) Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. J Clin Endocrinol Metab 89:1950–6

    Article  CAS  PubMed  Google Scholar 

  • Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR et al (2002) Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Clin Cancer Res 8:3669–75

    CAS  PubMed  Google Scholar 

  • Chang YS, Wang L, Suh YA, Mao L, Karpen SJ, Khuri FR et al (2004) Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer. Oncogene 23:6569–80

    Article  CAS  PubMed  Google Scholar 

  • Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Kollermann J et al (2006a) Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res 12:5040–6

    Article  CAS  PubMed  Google Scholar 

  • Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Miller K et al (2006b) Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder. Int J Cancer 119:1396–402

    Article  CAS  PubMed  Google Scholar 

  • Collard TJ, Guy M, Butt AJ, Perks CM, Holly JM, Paraskeva C et al (2003) Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis 24:393–401

    Article  CAS  PubMed  Google Scholar 

  • Colston KW, Perks CM, Xie SP, Holly JM (1998) Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol 20:157–62

    Article  CAS  PubMed  Google Scholar 

  • Cubbage ML, Suwanichkul A, Powell DR (1990) Insulin-like growth factor binding protein-3. organization of the human chromosomal gene and demonstration of promoter activity. J Biol Chem 265:12642–9

    CAS  PubMed  Google Scholar 

  • Dar AA, Majid S, Nosrati M, de Semir D, Federman S, Kashani-Sabet M (2010) Functional modulation of IGF-binding protein-3 expression in melanoma. J Investig Dermatol 130:2071–9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, Ropero S et al (2004) A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 64:5527–34

    Article  CAS  PubMed  Google Scholar 

  • Gigek CO, Leal MF, Lisboa LC, Silva PN, Chen ES, Lima EM et al (2010) Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma. Growth Hormon IGF Res 20:234–8

    Article  CAS  Google Scholar 

  • Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389:349–52

    Article  CAS  PubMed  Google Scholar 

  • Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG (1996) Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545–50

    CAS  PubMed  Google Scholar 

  • Hanafusa T, Yumoto Y, Nouso K, Nakatsukasa H, Onishi T, Fujikawa T et al (2002) Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett 176:149–58

    Article  CAS  PubMed  Google Scholar 

  • Hanafusa T, Shinji T, Shiraha H, Nouso K, Iwasaki Y, Yumoto E et al (2005) Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. BMC Cancer 5:9

    Article  PubMed Central  PubMed  Google Scholar 

  • Harada A, Jogie-Brahim S, Oh Y (2013) Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells. Lung Cancer 80:270–7

    Article  PubMed  Google Scholar 

  • He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–31

    Article  CAS  PubMed  Google Scholar 

  • Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S (2014) Use of epigenetic drugs in disease: an overview. Genetics & Epigen 6:9–19

    CAS  Google Scholar 

  • Holly JM, Zeng L, Perks CM (2013) Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? Cancer Metastasis Rev 32(3–4):673–705

    Article  PubMed Central  PubMed  Google Scholar 

  • Huynh H, Pollak M (1994) Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression. Cancer Res 54:3115–9

    CAS  PubMed  Google Scholar 

  • Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P (2006) Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 66:5021–8

    Article  CAS  PubMed  Google Scholar 

  • Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguan-Garcia C et al (2010) IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Oncogene 29:1681–90

    Article  CAS  PubMed  Google Scholar 

  • Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL et al (2002) Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 38:2362–70

    Article  CAS  PubMed  Google Scholar 

  • Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074–80

    Article  CAS  PubMed  Google Scholar 

  • Johnson MA, Firth SM (2014) IGFBP-3: A cell fate pivot in cancer and disease. Growth Hormon IGF Res 24(5):164–73

    Article  CAS  Google Scholar 

  • Kew MC (2011) Hepatitis B, virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol 26(Suppl 1):144–52

    Article  CAS  PubMed  Google Scholar 

  • Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC (2014) Epigenetic therapy of cancer with histone deacetylase inhibitors. J Cancer Res Ther 10:469–78

    CAS  PubMed  Google Scholar 

  • LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143–63

    Article  CAS  PubMed  Google Scholar 

  • Lin WH, Martin JL, Marsh DJ, Jack MM, Baxter RC (2011) Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells. J Biol Chem 286:29540–7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lo R, Weksberg R (2014) Biological and biochemical modulation of DNA methylation. Epigenomics 6:593–602

    Article  CAS  PubMed  Google Scholar 

  • Marino-Ramirez L, Kann MG, Shoemaker BA, Landsman D (2005) Histone structure and nucleosome stability. Expert Rev Proteomics 2:719–29

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • McCaig C, Fowler CA, Laurence NJ, Lai T, Savage PB, Holly JM et al (2002a) Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells. Br J Cancer 86:1963–9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • McCaig C, Perks CM, Holly JM (2002b) Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci 115:4293–303

    Article  CAS  PubMed  Google Scholar 

  • Miranda TB, Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213:384–90

    Article  CAS  PubMed  Google Scholar 

  • Momparler RL (2005) Epigenetic therapy of cancer with 5-aza-2’-deoxycytidine (decitabine). Semin Oncol 32:443–51

    Article  CAS  PubMed  Google Scholar 

  • Ng CK, Schultheis AM, Bidard FC, Weigelt B, Reis-Filho JS (2015) Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights. Journal of the National Cancer Institute. 107:(5)

  • Ohashi H, Adachi Y, Yamamoto H, Taniguchi H, Nosho K, Suzuki H et al (2012) Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers. Cancer Sci 103:252–61

    Article  CAS  PubMed  Google Scholar 

  • Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Florenes VA (2010) Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma. Int J Cancer 126:350–61

    Article  PubMed  Google Scholar 

  • Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH et al (2007) Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132:1476–94

    Article  CAS  PubMed  Google Scholar 

  • Perks CM, Holly JM (2008) IGF binding proteins (IGFBPs) and regulation of breast cancer biology. J Mammary Gland Biol Neoplasia 13:455–69

    Article  PubMed  Google Scholar 

  • Pernia O, Belda-Iniesta C, Pulido V, Cortes-Sempere M, Rodriguez C, Vera O et al (2014) Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy. Epigen Off J DNA Methylation Soc 9:1446–53

    Article  Google Scholar 

  • Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RW et al (2007) In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. Br J Cancer 96:1587–94

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Regel I, Eichenmuller M, Joppien S, Liebl J, Haberle B, Muller-Hocker J et al (2012) IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors. Mol Cancer 11:9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Santi DV, Norment A, Garrett CE (1984) Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. Proc Natl Acad Sci U S A 81:6993–7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Torng PL, Lin CW, Chan MW, Yang HW, Huang SC, Lin CT (2009) Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma. Mol Cancer 8:120

    Article  PubMed Central  PubMed  Google Scholar 

  • Wiley A, Katsaros D, Chen H, de la Rigault Longrais IA, Beeghly A, Puopolo M et al (2006a) Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer 107:299–308

    Article  CAS  PubMed  Google Scholar 

  • Wiley A, Katsaros D, Fracchioli S, Yu H (2006b) Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer. Int J Gynecol Cancer 16:210–8

    Article  CAS  PubMed  Google Scholar 

  • Yang G, Lu X, Yuan L (1839) LncRNA: a link between RNA and cancer. Biochim Biophys Acta 2014:1097–109

    Google Scholar 

  • Zeng L, Jarrett C, Brown K, Gillespie KM, Holly JM, Perks CM (2013) Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2’-deoxycytidine (AZA) in breast cancer cells. Exp Cell Res 319:2282–95

    Article  CAS  PubMed  Google Scholar 

  • Zhang B, Pan X, Cobb GP, Anderson TA (2007a) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1–12

    Article  CAS  PubMed  Google Scholar 

  • Zhang B, Wang Q, Pan X (2007b) MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210:279–89

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IGF & Metabolic Endocrinology Group, School of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol, BS10 5NB, UK

    Claire M Perks & Jeff MP Holly

Authors
  1. Claire M Perks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeff MP Holly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claire M Perks.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perks, C.M., Holly, J.M. Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer. J. Cell Commun. Signal. 9, 159–166 (2015). https://doi.org/10.1007/s12079-015-0294-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12079-015-0294-6

Keywords

Search

Navigation